We are live on ! Find out more
GC

GatePass Capital Portfolio holdings

AUM $214M
1-Year Est. Return 29.83%
This Fund
S&P 500
This Quarter Est. Return
+12.99%
1 Year Est. Return
+29.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$151M
AUM Growth
+$17.3M
Cap. Flow
+$5.25M
Cap. Flow %
3.48%
Top 10 Hldgs %
45.85%
Holding
131
New
17
Increased
41
Reduced
42
Closed
5

Sector Composition

Rank Sector Weight
1 Financials 18.65%
2 Consumer Discretionary 5.74%
3 Technology 5.27%
4 Industrials 3.33%
5 Consumer Staples 2.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDRX icon
126
GoodRx Holdings
GDRX
$1.04B
$49.8K 0.03%
10,000
BSV icon
127
Vanguard Short-Term Bond ETF
BSV
$44.7B
-3,339
Closed -$261K
INMB icon
128
INmune Bio
INMB
$44.9M
-235,000
Closed -$1.84M
IWM icon
129
iShares Russell 2000 ETF
IWM
$80B
-2,042
Closed -$407K
UNH icon
130
UnitedHealth
UNH
$380B
-422
Closed -$221K
EQC
131
DELISTED
Equity Commonwealth
EQC
-69,260
Closed -$112K

Similar funds

GatePass Capital's Q2 2025 Portfolio in Review

As of Q2 2025, GatePass Capital held 131 positions worth $151M, up 13% from $134M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GatePass Capital deployed $5.25M of net new capital in Q2 2025, opening 17 new positions and adding to 41 existing holdings. Its largest new stake was iShares Broad USD High Yield Corporate Bond ETF: 22,600 shares worth $848K.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF, an estimated $672K trimmed.

  • GatePass Capital's largest Q2 2025 buy was iShares Broad USD High Yield Corporate Bond ETF: 22,600 shares worth $848K.
  • GatePass Capital added most to WisdomTree Floating Rate Treasury Fund in Q2 2025, an estimated $2.98M increase.
  • GatePass Capital's biggest Q2 2025 reduction was GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF, cutting an estimated $672K.
  • GatePass Capital fully exited INmune Bio in Q2 2025, selling an estimated $1.84M.
  • GatePass Capital's ten largest holdings make up 46% of its $151M portfolio in Q2 2025.
  • GatePass Capital opened 17 new positions and closed 5 in Q2 2025.
  • GatePass Capital's portfolio value rose 13% quarter-over-quarter to $151M.

Based on GatePass Capital's 13F filing for Q2 2025, filed 22 Sep 2025.